Kala pharmaceuticals stock news
Webb27 okt. 2024 · Good news from the FDA translated to bad news for Kala's share price. What happened Shares of Kala Pharmaceuticals ( KALA 0.66% ) were sinking 17.4% as of 3:30 p.m. EDT on Tuesday. Webb14 apr. 2024 · Some better-ranked stocks for investors interested in the same sector are CRISPR Therapeutics CRSP, Kala Pharmaceuticals KALA and Allogene Therapeutics ALLO, each carrying a Zacks Rank #2 (Buy) at ...
Kala pharmaceuticals stock news
Did you know?
WebbKala Pharmaceuticals, Inc. (KALA) Stock Price, News, Quote & History - Yahoo Finance Kala Pharmaceuticals, Inc. (KALA) NasdaqCM - NasdaqCM Real Time Price. … Webb19 maj 2024 · On January 19, 2024, Kala Pharmaceuticals, Inc., a Delaware corporation (the "Company"), entered into an Open Market Sale AgreementSM (the "Sales Agreement") with Jefferies LLC, as agent ("Jefferies"), pursuant to which the Company may offer and sell shares of its common stock, $0.001 par value per share (the "Common …
Webb12 apr. 2024 · Kala Pharmaceuticals Receives FDA Fast Track Designation for KPI-012, a Human MSC-S Therapy for Persistent Corneal Epithelial Defect. ARLINGTON, Mass., … Webb6 apr. 2024 · The reverse stock split will become effective at 4:05 p.m. on Thursday, October 20, 2024. Kala’s common stock will continue to be traded on the Nasdaq …
Webb13 apr. 2024 · KALA PHARMACEUTICALS INC-Investoren interessieren sich auch für diese News. Der DAX wurde gestern durch die steigenden Ölpreise leicht ausgebremst. So ging es für den Leitindex um 0,3 Prozent ... WebbThe current KALA stock price $13.9 has increased 74.50% from its 52-week low Does KALA stock pay dividends? No, the KALA stock does not pay dividends to its shareholders What is KALA stock price target? The target price for KALA stock is $150 based on the average of what a group of analyst think KALA stock could be worth at a …
Webb13 apr. 2024 · Kala Pharmaceuticals currently has a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.. InflaRx Surges on EUA for Gohibic: InflaRx N.V.IFRX ...
Webbför 2 dagar sedan · Kala Pharmaceuticals Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapeutics using … f command\\u0027sWebb15 mars 2024 · View the latest Kala Pharmaceuticals Inc. (KALA) stock price, news, historical charts, analyst ratings and financial information from WSJ. f command\u0027sWebb28 dec. 2024 · The Food and Drug Administration has accepted Kala's investigational drug application for KPI-012, a potential treatment for persistent corneal epithelial defect, or … fritz box rotes lichtWebb13 apr. 2024 · Latest Kala Pharmaceuticals Inc Stock News. As of April 06, 2024, Kala Pharmaceuticals Inc had a $27.8 million market capitalization, putting it in the 20th percentile of companies in the Pharmaceuticals industry. Kala Pharmaceuticals Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months. fcommandWebb6 apr. 2024 · NASDAQ:KALA Kala Pharmaceuticals - KALA News Today $15.05 +0.45 (+3.08%) (As of 03/31/2024 12:00 AM ET) Compare Today's Range $14.21 $15.10 50 … fritzbox rotes licht infoWebb11 apr. 2024 · In February 2024, Kala dosed the first patient in its CHASE (Corneal Healing After SEcretome therapy) Phase 2b trial evaluating KPI-012 for the treatment of PCED. In March 2024, Kala announced positive safety data from the first cohort of two patients that were treated with a high dose of KPI-012 (3 U/mL) four times per day … f community\u0027sWebb12 apr. 2024 · The trading price of Kala Pharmaceuticals Inc. (NASDAQ:KALA) floating higher at last check on Wednesday, April 12, closing at $17.86, 4.81% higher than its previous close. Traders who pay close attention to intraday price movement should know that it has been fluctuating between $13.62 and $17.7999. fritzbox reverse proxy